EUVIMEDEUVIMED entdecken
Crossref

Interpreting the Model: Biologic Pathways Underlying a Clinically Validated Multimodal Digital Pathology AI Biomarker in Metastatic Prostate Cancer

P. Sutera, A. Shetty, Y. Song, A. Mendes, R. Yamashita, E. Stewart, T.N. Showalter, A. Berlin, A.P. Kiess, D. Song, S. Supiot, P.R.P. Dirix und 8 weitere

International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · S147-S148

DOI: 10.1016/j.ijrobp.2026.06.228 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von P. Sutera und 19 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Prostate cancer (PCa) spans indolent localized to lethal metastatic castration-resistant disease, underscoring the need for biologically grounded risk tools. ArteraAI multimodal artificial intelligence (MMAI), an NCCN guideline–supported biomarker for localized PCa and backed by Simon Level 1B evidence, has been validated as a prognostic marker across the spectrum of PCa. As an AI model incorporating a self-supervised learning (SSL) component, aspects of MMAI remain, non–human-interpretable, as the specific features learned by the SSL are

Zitieren

APA

Sutera, P., Shetty, A., Song, Y., Mendes, A., Yamashita, R., Stewart, E., Showalter, T., Berlin, A., Kiess, A., Song, D., Supiot, S., Dirix, P., Mercier, C., Onal, H., Ost, P., Kagohara, L., Lotan, T., Zhao, S., Deek, M., & Tran, P. (2026). Interpreting the Model: Biologic Pathways Underlying a Clinically Validated Multimodal Digital Pathology AI Biomarker in Metastatic Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics, 126(1), S147-S148. https://doi.org/10.1016/j.ijrobp.2026.06.228

Vancouver

Sutera P, Shetty A, Song Y, Mendes A, Yamashita R, Stewart E, et al. Interpreting the Model: Biologic Pathways Underlying a Clinically Validated Multimodal Digital Pathology AI Biomarker in Metastatic Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):S147-S148. doi:10.1016/j.ijrobp.2026.06.228

BibTeX
@article{Sutera2026,
  author = {Sutera, P. and Shetty, A. and Song, Y. and Mendes, A. and Yamashita, R. and Stewart, E. and Showalter, T.N. and Berlin, A. and Kiess, A.P. and Song, D. and Supiot, S. and Dirix, P.R.P. and Mercier, C. and Onal, H.C. and Ost, P. and Kagohara, L.T. and Lotan, T.L. and Zhao, S.G. and Deek, M.P. and Tran, P.T.},
  title = {Interpreting the Model: Biologic Pathways Underlying a Clinically Validated Multimodal Digital Pathology AI Biomarker in Metastatic Prostate Cancer},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  volume = {126},
  number = {1},
  pages = {S147--S148},
  doi = {10.1016/j.ijrobp.2026.06.228}
}
Kostenlos starten →